From the Uppsala monitoring centre: a review of viewpoint part 1 and part 2.
The core task of the Uppsala Monitoring Centre (UMC) is the collection and processing of adverse drug reaction reports from member countries of the WHO Programme for International Drug Monitoring to detect early signals of potential drug hazards. Also a high priority is the communication of information about drug safety issues to the widest possible professional and general audiences in order to improve patient safety and welfare. The publication of the two parts of the publication Viewpoint represents a pioneering effort to provide easily accessible information on international pharmacovigilance for lay and specialist readers.